Introduction To quantify early nonadherence to antipsychotic medications in patients with
schizophrenia and its impact on short-term antipsychotic adherence, healthcare utilization …

Purpose There is strong evidence supporting the link between nonadherence to
antipsychotic medication and relapse of schizophrenia. However, less obvious are the …

Objective: To review the literature addressing the economic outcomes of nonadherence in
the treatment of schizophrenia, and to utilize the review results to provide an update on the …

BACKGROUND: Poor medication adherence contributes to negative treatment response,
symptom relapse, and hospitalizations in schizophrenia. Many health plans use claims …

Nonadherence to antipsychotic medications is widespread and compromises the outcome of
patients with schizophrenia. Using the MarketScan Medicare claims database, this study …

Objective: This analysis assessed rates of medication adherence and pre-dictors of
nonadherence and hospitalization among patients treated with long-acting injectable and …

Background Nonadherence with antipsychotic medication is an important clinical and
economic problem in the treatment of schizophrenia. This study identified treatment patterns …

To assess baseline predictors and consequences of antipsychotic adherence during long-
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …

BACKGROUND: Medication nonadherence to antipsychotic drugs, which is commonly seen
in patients with schizophrenia who have comorbidities, not only affects the quality of life of …

Background Adherence to antipsychotics for schizophrenia is associated with favorable
clinical outcomes. This study compared annual mental-health service utilization by recent …